New treatment option for Neuromodulation
Official title Optimization of ITBS for Depression
ClinicalTrials.gov ID: NCT06464445
What this study is testing
- What it's testing
- Repetitive TMS (rTMS) is a well-established method for modulating brain activity. Through successive stimulations in the form of magnetic fields, it is possible to modify the sensitivity of neurons in the brain, also known as cortical excitability.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35. Healthy volunteers may be eligible.
You may be able to join if
- Be between 18 and 35 years old
- Be of right manual dominance
- In good health
You likely can't join if
- Have an implant or pacemaker,
- Having tinnitus,
- Have a history of fainting,
- Have already had an epileptic seizure or have a family history of epilepsy,
- Have a known neurological disease,
- Be under psychotropic medication,
See the full eligibility criteria
- Be between 18 and 35 years old
- Be of right manual dominance
- In good health
- Have an implant or pacemaker,
- Having tinnitus,
- Have a history of fainting,
- Have already had an epileptic seizure or have a family history of epilepsy,
- Have a known neurological disease,
- Be under psychotropic medication,
- Have suffered from substance abuse or dependence in the last 6 months,
- Have a neurostimulator,
- Have a splinter or metallic implant in the head or the rest of the body,
- Have a cochlear implant,
- Have an automated injection system implanted (insulin pump),
- Have a transdermal patch,
- Have tattoos in the area to be studied,
- Be pregnant or breastfeeding,
The study team makes the final eligibility decision.
Where it's taking place
- Sherbrooke, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sherbrooke, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.